Financials
- Market Capitalization 45.45 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.91
売上高対価格比率
-67.95
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4289 | EDSA Edesa Biotech, Inc. - Common Shares | 4.74 USD | +2.60% | +7.97% | -6.88% | +97.50% | 45.70 M USD | ||
| 4290 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.94 USD | 0.00% | +8.05% | +161.11% | -27.69% | 45.68 M USD | ||
| 4297 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.13 USD | +0.47% | -3.62% | 0.00% | -46.48% | 44.81 M USD | ||
| 4302 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.18 USD | -0.84% | -3.28% | -0.84% | -18.06% | 44.58 M USD |